The theory of information was initially developed by Claude E. Shannon in the 1940s, and since then has grown in importance due to its practical applications in the field of data compression and computing. In its simplest form, information theory states that if a given message conveys information, then that message must be structured in a way that allows its meaning to be understood. This structure is known as the language of information, which consists of symbols and syntax that represent the meaning of the message. In order for a message to contain useful information, these symbols must be encoded into the language of information, giving each symbol a unique, numerical representation. This numerical representation can then be used to represent the original message in a more efficient manner than the traditional language of communication. In addition to encoding messages in language, the theory of information also deals with the transmission, storage, and retrieval of the message. These operations involve various techniques such as the use of codes, algorithms, compression techniques, and error correction techniques. In addition, information theory also takes into account the amount of redundancy that is present in a communication channel, and investigates methods of minimizing it in order to maximize the efficiency of transmitting data over a given channel. Finally, information theory can also be applied to the study of Artificial Intelligence, since it can help to provide insights into the way in which bots and other AI-enabled systems process and respond to information.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States